(Q77128596)

English

A review of GERCOD trials of bimonthly leucovorin plus 5-fluorouracil 48-h continuous infusion in advanced colorectal cancer: evolution of a regimen. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD)

scientific article published on 01 April 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9713264%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

Europe PubMed Central

A review of GERCOD trials of bimonthly leucovorin plus 5-fluorouracil 48-h continuous infusion in advanced colorectal cancer: evolution of a regimen. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD) (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9713264%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

colorectal cancer

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9713264%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

author name string

A de Gramont

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9713264%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

C Louvet

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9713264%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

C Tournigand

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9713264%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

M Krulik

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9713264%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

publication date

1 April 1998

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9713264%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

European Journal of Cancer

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9713264%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

34

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9713264%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

619-626

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9713264%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9713264%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900364-X

7 January 2021

based on heuristic

inferred from DOI database lookup

5-Fluorouracil and folinic acid in the treatment of metastatic colorectal cancer: a randomized comparison. A Southwest Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900364-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900364-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900364-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900364-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900364-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900364-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900364-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900364-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorouracil: biochemistry and pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900364-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900364-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900364-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III study of bolus versus infusion fluorouracil with or without cisplatin in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900364-X

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900364-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900364-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Bimonthly high dose leucovorin and 5-fluorouracil 48-hour continuous infusion in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900364-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900364-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900364-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Synergism and lack of cross-resistance between short-term and continuous exposure to fluorouracil in human colon adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900364-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900364-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of weekly 24-hour infusion with high-dose fluorouracil with leucovorin in colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900364-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Antitumor activity of a new platinum complex, oxalato (trans-l-1,2-diaminocyclohexane)platinum (II): new experimental data

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900364-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900364-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900364-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(97)00364-X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9713264%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9713264%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77128596&oldid=1753440261"